Is AMPX a Buy? What to Consider in 2026

Short answer

The bull case for Amprius Technologies (AMPX) rests on Energy-density edge: Amprius's core pitch is that silicon-anode cells store more energy per unit of weight and volume than conventional lithium-ion. Revenue (FY2025) is ~$73.0 million (up over 3x year over year). If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: Amprius is in an early commercial ramp and is not yet consistently profitable, so it depends on its cash balance and may need to raise capital, which can dilute shareholders. Whether AMPX is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.

Amprius Technologies develops and sells silicon-anode lithium-ion batteries that target higher energy density than conventional graphite-anode cells, meaning more energy in the same weight and volume. Its SiMaxx platform uses a proprietary 100% silicon-nanowire anode made in-house at its Fremont, California facility and is positioned for the most demanding high-performance uses, while its newer SiCore platform is a commercially available silicon-anode line, including a 450 Wh/kg cell, designed for near-term mass production. Higher energy density matters most where weight is critical, which is why Amprius concentrates on aviation, electric vertical takeoff and landing (eVTOL) aircraft, drones, defense, and electric vehicles. The company ships cells to a broad and growing base of customers and holds defense agreements such as a contract with the U.S. Defense Innovation Unit for NDAA-compliant advanced drone batteries. Amprius was founded out of silicon-anode research and went public in 2022 through a SPAC merger, trading on the New York Stock Exchange under the ticker AMPX. The company is in an early commercial ramp: revenue has grown quickly off a small base, but it remains unprofitable. A notable strategic shift came in January 2026, when Amprius terminated a 15-year lease for a planned Brighton, Colorado manufacturing facility for roughly $20 million, eliminating an obligation it valued at over $110 million, and moved toward a capital-light model that uses external contract manufacturers (including a Korea-based alliance) to add capacity with less fixed investment. The company continues to operate and expand pilot and production lines at Fremont while routing volume scale-up through partners.

What's the case for buying AMPX?

Energy-density edge.

Amprius's core pitch is that silicon-anode cells store more energy per unit of weight and volume than conventional lithium-ion. In weight-sensitive uses such as drones, eVTOL, and aviation, that can translate into longer flight time or range, which is the central reason customers and investors track the company. SiCore is positioned as a commercially available, scalable line, and SiMaxx targets the highest-performance niche.

Aviation, defense, and drone demand.

The company has concentrated revenue in drones and aviation and holds defense agreements, including an expanded contract with the U.S. Defense Innovation Unit covering multiple cylindrical and pouch cell formats. Defense and aviation buyers value energy density and domestic, NDAA-compliant supply, which gives Amprius a differentiated wedge versus commodity lithium-ion suppliers.

Capital-light manufacturing scale-up.

After canceling its planned Brighton, Colorado factory, Amprius shifted to a contract-manufacturing model, signing partnerships (including a Korea-based alliance) to secure hundreds of MWh of SiCore capacity with limited capital spending. The aim is to add production quickly while preserving cash, though it makes the company dependent on partners for quality, timing, and cost.

Early-commercial revenue ramp.

Revenue has been growing rapidly off a small base, and management has guided to continued strong growth alongside a narrowing loss. The investment question is whether that ramp can continue at scale and convert into durable gross margin and eventual profitability, rather than remaining a series of project and pilot wins.

What are the risks to AMPX?

Amprius is in an early commercial ramp and is not yet consistently profitable, so it depends on its cash balance and may need to raise capital, which can dilute shareholders. The capital-light strategy concentrates execution risk in contract manufacturers, and revenue has historically been concentrated in a small number of customers and end markets such as drones and defense, where order timing can be lumpy. Competition is intense, from large established lithium-ion makers steadily improving their cells to other silicon-anode and next-generation battery startups. The stock is volatile and sensitive to order news, guidance changes, and shifts in defense, drone, and EV demand.

How is AMPX valued? (as of Q1 2026 (reported May 2026))

Revenue (FY2025): ~$73.0 million (up over 3x year over year)
Revenue (Q1 2026): ~$28.5 million (up ~153% year over year)
Net loss (FY2025): ~$44.0 million (incl. ~$22.5M Colorado impairment; ~$21.5M adjusted)
Cash and equivalents: ~$91.9 million reported at end of 2025 (verify latest)
2026 revenue guidance: ~at least $130 million; net loss guided below ~$8 million
Market cap: ~$1.9 to $2.3 billion, highly variable (verify)

Amprius is a speculative, ramp-stage company, so it cannot be valued on current earnings; the market prices it largely on the option value of future growth and scale. Figures are approximate and change frequently, especially cash, share count, and market cap, which capital raises and dilution can move materially. Verify the latest filings before relying on any number.

How do you decide if AMPX is a buy?

Rather than asking whether AMPX is a buy in the abstract, it tends to help to answer four questions:

Thesis: do you believe the case above, and is it still true today?
Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
Overlap: check whether you already hold AMPX indirectly through an index or sector ETF before adding more.

For the full picture, see the AMPX stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about AMPX against your real portfolio and see your actual exposure before deciding.

The bottom line on AMPX

The bottom line: Amprius Technologies's story right now is Energy-density edge, with revenue (fy2025) at ~$73.0 million (up over 3x year over year). If you believe that narrative continues, the call is about sizing AMPX sensibly and checking overlap with what you own; if you doubt it (the risk: amprius is in an early commercial ramp and is not yet consistently profitable, so it depends on its cash balance and may need to raise capital, which can dilute shareholders.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.

Build a basket around AMPX with Walnut

Use Amprius Technologies as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.

Create a free Walnut account

FAQ

Is AMPX a good stock to buy right now?

The case for Amprius Technologies right now is Energy-density edge, with revenue (fy2025) at ~$73.0 million (up over 3x year over year). If you believe that thesis holds, AMPX is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is amprius is in an early commercial ramp and is not yet consistently profitable, so it depends on its cash balance and may need to raise capital, which can dilute shareholders. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.

What does Amprius Technologies do?

Amprius Technologies develops and sells silicon-anode lithium-ion batteries that target higher energy density than conventional graphite-anode cells, meaning more energy in the sam

What are the main risks of AMPX?

What does Amprius do?

Amprius Technologies develops and sells silicon-anode lithium-ion batteries with higher energy density than conventional graphite-anode cells. Its SiMaxx platform uses a 100% silicon-nanowire anode made in Fremont, California, and its SiCore platform is a commercially available, scalable line. The cells target aviation, eVTOL, drones, defense, and electric vehicles, where light weight and long runtime matter most.

What is AMPX's ticker symbol and where does it trade?

Amprius Technologies trades under the ticker AMPX on the New York Stock Exchange. The company is headquartered in Fremont, California, and went public in 2022 through a SPAC merger. It trades during US market hours and is available at every major US brokerage, including as fractional shares at brokers that offer them.

Is AMPX profitable?

No. Amprius is in an early commercial ramp and has been unprofitable, reporting a net loss for 2025 that included a large Colorado facility impairment. Management has guided toward a much smaller loss in 2026 as revenue scales, but the company still relies on its cash balance and could raise additional capital. Verify the latest filings for current results.

Does AMPX pay a dividend?

No. Amprius Technologies does not pay a dividend. As an early-commercial, growth-focused company that is reinvesting in product development and manufacturing capacity, it directs cash toward scaling the business rather than returning it to shareholders, and is not expected to pay a dividend in the foreseeable future.

Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell AMPX; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.